Streetbeat News

Earnings

BBU

BBUC

Brookfield Business Partners (NYSE: BBU, BBUC) reported its financial results for the third quarter of 2024, ending on September 30, 2024.

Portfolio Pulse from

November 08, 2024 | 12:00 pm

PSIX

Power Solutions International (PSIX) has experienced a significant increase in share price due to its strategic focus on high-growth markets such as data centers. The company's Q3 earnings report reveals a 9% year-over-year revenue growth, with the Power Systems segment growing by nearly 40%, enhancing profitability. PSIX's clean balance sheet and successful debt refinancing offer financial flexibility for future growth, with a projected 50% upside potential.

Portfolio Pulse from

November 08, 2024 | 12:00 pm

WMS

Advanced Drainage Systems reported its fiscal Q2 2025 results with net sales of $782.6 million, flat compared to the previous year. Net income decreased by 4.3% to $131.2 million, and net income per diluted share fell by 2.3% to $1.67.

Portfolio Pulse from

November 08, 2024 | 12:00 pm

CROX

Crocs' Q3 results exceeded guidance, but the stock dropped due to slower revenue growth and HeyDude's underperformance. Despite strong EPS growth, investors are concerned about revenue slowdown. The international segment, especially in China, shows significant long-term potential.

Portfolio Pulse from

November 08, 2024 | 12:00 pm

IEP

Icahn Enterprises L.P. (Nasdaq: IEP) announced its third quarter 2024 financial results. The announcement was made by Chairman Carl C. from Sunny Isles Beach, Florida.

Portfolio Pulse from

November 08, 2024 | 12:00 pm

YMAB

Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB) reported its financial results for the third quarter of 2024, highlighting its focus on developing and commercializing cancer treatments.

Portfolio Pulse from

November 08, 2024 | 12:00 pm

BEP

Brookfield Renewable Partners L.P. announced record financial results for the third quarter of 2024, highlighting strong performance and growth.

Portfolio Pulse from

November 08, 2024 | 12:00 pm

OCGN

Ocugen, Inc. reported its Q3 2024 financial results and provided a business update. The company closed a $30 million debt financing and is progressing with its clinical trials, including OCU400 and OCU410. New data from these trials will be presented at an upcoming Clinical Showcase.

Portfolio Pulse from

November 08, 2024 | 12:00 pm

ET

Energy Transfer is achieving record-setting results, driven by its ongoing expansion initiatives and recent acquisitions, which are boosting its volumes and earnings.

Portfolio Pulse from

November 08, 2024 | 12:00 pm

STRW

Strawberry Fields REIT announced its Q3 2024 operating results, highlighting 100% rent collection and declared a $0.14 cash dividend per share.

Portfolio Pulse from

November 08, 2024 | 11:45 am